ATXN2 and gastric cancer: In summary, our study revealed that the SP1/ATXN2/PI3K-AKT/BCL2L1 pathway promotes GC chemoresistance and that the SP1/ATXN2/PI3K-AKT/PD-L1 pathway promotes GC immune escape.